by John Conrad | Jan 8, 2025 | Grants, NewsBrief
In partnership with G2G Consulting, we are please to provide the January 2025 Grants report, showcasing 196 non-dilutive government funding opportunities across diverse biomedical and life sciences sectors. The comprehensive report underscores significant funding...
by John Conrad | Dec 18, 2024 | iBIO News
As Illinois’ life sciences industry continues its remarkable growth trajectory, iBIO President and CEO John Conrad and iBIO Board Chair Ken Johnson, Senior Vice President of Global Development and Medical Affairs at Xeris Pharmaceuticals, sat down to discuss the...
by John Conrad | Nov 14, 2024 | iBIO News
In a significant move to enhance science education across Illinois, the Illinois Biotechnology Innovation Organization (iBIO) has launched its innovative “LabShare” program. This groundbreaking program connects surplus laboratory equipment from iBIO member...
by John Conrad | Sep 26, 2024 | Member News
ARCH Venture Partners, the Chicago-based venture capital firm known for its bold bets in biotechnology, has once again demonstrated its commitment to driving healthcare innovation. The firm announced on September 26, 2024, that it has raised $3 billion for its...
by John Conrad | Jul 25, 2024 | iBIO News
We’re trying something new! Welcome to the first NewsBrief Innovation Insider Interview, where we chat with leaders from the biotech, pharma, medtech, venture capital and science community and explore cutting-edge ideas and strategies to help you gain actionable...
